Asst. Prof. Sıla GÜLBAĞ PINAR

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

The Possible Protective Effect of Boric Acid in an Alkaline-Induced Corneal Neovascularization Rat Model

KARACA U., GÜLBAĞ PINAR S., SAVRAN M., USTA SOFU G., İLHAN İ., ÖZKAYA D., et al.

BIOLOGICAL TRACE ELEMENT RESEARCH, vol.200, no.12, pp.5127-5133, 2022 (SCI-Expanded)

A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation

Pınar S., CANPINAR H., TAN Ç., Çelebi N.

European Journal of Pharmaceutical Sciences, vol.171, 2022 (SCI-Expanded)

Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines

Pinar S., PEZİK E., MUTLU AĞARDAN N. B., Celebi N.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, vol.27, no.1, pp.52-62, 2022 (SCI-Expanded)

New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system

Gulbag S., Usta D. Y., Gultekin H. E., Oktay A. N., Demirtas O., Karakucuk A., et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, vol.23, no.5, pp.512-519, 2018 (SCI-Expanded)

Articles Published in Other Journals

Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method

Pinar S., Celebi N.

JOURNAL OF RESEARCH IN PHARMACY, vol.23, no.6, pp.1009-1021, 2019 (ESCI)

Cyclosporine A and New Approaches to Cylosporine A Formulations

GÜLBAĞ S., ÇELEBİ F. N.

FABAD Journal of Pharmaceutical Sciences, 2017 (Scopus)

Refereed Congress / Symposium Publications in Proceedings

Evaluation of Biochemical and Immunological Parameters of New Developed Cyclosporine A Nanosuspension

Gülbağ Pınar S., Fidan H. K., Tan Ç., Çelebi F. N.

20th International Pharmaceutical Technology Symposium (IPTS 2022), Ankara, Turkey, 21 - 23 February 2022, pp.105-107

Memantine Loaded PLGA Nanoparticles for Alzheimer’s Disease Part-1: In-vitro Characterization

Tezel G., Reçber T., Timur S. S., Nemutlu E., Gülbağ Pınar S., Eroğlu H.

20th International Pharmaceutical Technology Symposium (IPTS 2022), Ankara, Turkey, 21 - 23 February 2022, pp.211-213

Covid-19 Tedavisinde Kullanılan Antiviral İlaçların Biyofarmasötik Yönden Değerlendirilmesi

Gülbağ Pınar S., Çelebi F. N.

3. Ulusal Sağlık Hizmetleri Sempozyumu, Isparta, Turkey, 19 - 20 November 2021, pp.103-106 Sustainable Development

The Effects of a New Cyclosporine A Nanosuspension on Nephrotoxicity After Oral Administration: HK-2 Cell Culture and In Vivo Histopathological Evaluation

Gülbağ Pınar S., Mutlu Ağardan N. B., Işık Gönül İ., Çelebi F. N.

Gazi Pharma Semposium Series (GPSS) 3, Ankara, Turkey, 8 - 10 September 2021, pp.31-32

Reçete Türleri ve Beşeri İlaç Şekillerine Kavramsal Yaklaşım - Conceptual Approach to Prescription Types And Human Drug Forms

Gülbağ Pınar S.

I. Uluslararası İlaç ve Eczacılık Hukuku Kongresi, Ankara, Turkey, 4 - 05 September 2021, pp.2-3

Immunological Effects of A New Developed Cyclosporine A Nanosuspension in Rats for Oral Administration

Gülbağ Pınar S., Tan Ç., Atak Yücel A., Çelebi F. N.

13th International Symposium on Pharmaceutical Sciences (ISOPS-13), Ankara, Turkey, 22 - 25 June 2021, pp.48-49

Cyclosporine A nanosuspension prepared with wet milling method using combined stabilizers: Pharmacokinetic and immunological evaluation in rats

Gülbağ Pınar S., Canpınar H., Çelebi F. N.

EUFEPS Annual Meeting 2021: Bridging the Gap Between the Patient and the Product Design, Gothenburg, Sweden, 7 - 09 June 2021, pp.35

Evaluation of Dissolution Properties of Cyclosporine a Nanosuspensions Prepared with Two Different Top Down Technologies

Gülbağ S., Mutlu Ağardan N. B., Çelebi F. N.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.85-86

The Effects of Process Parameters of the Cyclosporine A Nanosuspension Produced by Wet Milling Stabilized with Hydroxypropyl methylcellulose

Gülbağ Pınar S., Karaküçük A. E., Mutlu Ağardan N. B., Çelebi F. N.

The 2019 Controlled Release Society Annual Meeting & Exposition (CRS 2019), Valencia, Spain, 21 - 24 July 2019

Development and Evaluation of Nanosuspension Formulations for Poorly Soluble Drugs Using Top Down Technologies

Gülbağ Pınar S., Oktay A. N., Çelebi F. N.

International Multidisciplinary Symposium on Drug Research and Development (DRD 2019), Malatya, Turkey, 1 - 03 July 2019, pp.92-94

Cyclosporine A Nanosuspension Produced by Wet Media Milling Method: Development and Characterization

Gülbağ Pınar S., Çelebi F. N.

EUFEPS Annual Meeting 2019: Personalized Medicines, Targeted Therapies, Precision Drug Delivery, Frankfurt, Germany, 6 - 08 March 2019, pp.115-116

Preformulation studies of cyclosporine A nanosuspension stabilized by hydroxypropyl methylcellulose and soluplus

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., Çelebi N.

12th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 26 - 29 June 2018

Top down production of cyclosporine A nanosuspensions: Formulation design and characterization for oral delivery

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., ÇELEBİ N.

EUFEPS Annual Meeting 2018, Atina, Greece, 24 - 26 May 2018

Preparation and characterization of cyclosporine A nanosuspensions for oral administration II: The effect of Poloxamer types on physical stability of formulations

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., Çelebi F. N.

11th WORLD MEETING on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Nicaragua, 19 - 21 March 2018

Preparation and characterization of cyclosporine nanosuspension for oral administration I: Effects of formulation parameters

GÜLBAĞ S., KARAKÜÇÜK A. E., ÇELEBİ F. N.

GPSS International Gazi Pharma Symposium Series 2, 11 - 13 October 2017

Books & Book Chapters

Current Formulation Approaches in Nutraceuticals